Wietske Kievit

8PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Reaction engineering (excl. nuclear reactions)Toxicology (incl. clinical toxicology)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic Evaluation.

Fenna de Vries, Eric J F Franssen, Arthur A J Smit

|Dec 28, 2020
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice.

S Atalay, J M P A van den Reek, J M M Groenewoud

|Nov 06, 2019
Correction to: Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low‑Dose Acetylsalicylic Acid Treatment.

Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg

|Sep 28, 2019
Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low-Dose Acetylsalicylic Acid Treatment.

Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg

|Aug 06, 2019
Social media monitoring on the perceived safety of medication use during pregnancy: A case study from the Netherlands.

Marleen M H J van Gelder, Annemarije Rog, Sebastian J H Bredie

|Oct 13, 2018
Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial.

Maaike Ferwerda, Sylvia van Beugen, Henriët van Middendorp

Pageof 2

Frequent Collaborators

2 joint publications

Selma Atalay

2 joint publications

Juul M P A van den Reek

2 joint publications

Michel Wensing

2 joint publications

Elke M G J de Jong